BOW MEDICAL PRACTICE
ITER CROSS, BOW, CREDITON
CHD 14
The percentage of patients with a history of myocardial infarction (from 1 April 2011) currently treated with an ACE inhibitor (or ARB if ACE intolerant), aspirin or an alternative anti-platelet therapy, beta blocker and statin (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CHD 11 | 2010 | 10 | 10 | 100.0% | |
| CHD 11 | 2011 | 8 | 10 | 80.0% | |
| CHD 14 | 2012 | 1 | 1 | 100.0% | |
| CHD 14 | 2013 | 5 | 5 | 100.0% | |
| CHD006 | 2014 | 5 | 5 | 100.0% | |
| CHD006 | 2015 | 8 | 8 | 100.0% |
